Loading chart...
Veru: "No, [I don't think Veru shares will increase as much as Moderna's did if Veru's Covid treatment receives emergency use clearance]. I think Veru also needs to have that expanded needs of breast cancer, too."
Loading chart...
ChargePoint: "It's the best one of a bad neighborhood, though. ... Here's the problem: ChargePoint is not making money and we can't recommend stocks that aren't making money in this environment. It's too hard."
Loading chart...
Jackson Financial: "I like that call. I like that call. Nice yield. Annuities [are a] good business."
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com